Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.22.B73: SENP5 peptidase

This is an abbreviated version!
For detailed information about SENP5 peptidase, go to the full flat file.

Word Map on EC 3.4.22.B73

Reaction

SENP5 additional information efficiently removes SUMO-2 and SUMO-3 than SUMO-1 from SUMO-modified target such as Ran GTPase-activating protein 1. Catalyzes desumoylation of mitochondrial fission GTPase DRP1. =

Synonyms

SENP5, SENP5 peptidase, sentrin/small ubiquitin-like modifier-specific protease5, SUMO isopeptidase, SUMO-specific protease 5

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.22 Cysteine endopeptidases
                3.4.22.B73 SENP5 peptidase

Disease

Disease on EC 3.4.22.B73 - SENP5 peptidase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Breast Neoplasms
SENP5 mediates breast cancer invasion via a TGF?RI SUMOylation cascade.
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.
Carcinogenesis
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.
Carcinoma
Inhibition of SENP5 suppresses cell growth and promotes apoptosis in osteosarcoma cells.
Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
Sentrin/small ubiquitin-like modifier-specific protease 5 protects oral cancer cells from oxidative stress-induced apoptosis.
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.
Cardiomyopathies
SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy.
Cardiomyopathy, Dilated
SUMOylation in cardiac disorders - a review.
Epilepsy
SUMO proteases SENP3 and SENP5 spatiotemporally regulate the kinase activity of Aurora A.
Glioblastoma
SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma.
Heart Failure
SUMOylation in cardiac disorders - a review.
Muscular Diseases
SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy.
Neoplasms
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.
Osteosarcoma
Inhibition of SENP5 suppresses cell growth and promotes apoptosis in osteosarcoma cells.
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.
Squamous Cell Carcinoma of Head and Neck
Inhibition of SENP5 suppresses cell growth and promotes apoptosis in osteosarcoma cells.
Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
Sentrin/small ubiquitin-like modifier-specific protease 5 protects oral cancer cells from oxidative stress-induced apoptosis.
The SUMO-specific protease SENP5 controls DNA damage response and promotes tumorigenesis in hepatocellular carcinoma.